Otsuka Pharmaceutical Netherlands B.V.

ACTIVE

NetherlandsPrivate

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

No trial phase data available

Trial Status Distribution

No trial data available

Clinical Trials

No trial data available

Approvals

Approvals by Agency

EMA

European Medicines Agency

Approvals

CIMA_AEMPS

Spanish Agency for Medicines and Medical Devices

Approvals

Recent Approvals

ABILIFY 30 MG COMPRIMIDOS

RXULTI 0,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

CIMA_AEMPS

2025-04-09

ABILIFY 30 MG COMPRIMIDOS

CIMA_AEMPS

2025-04-09

ABILIFY 10 MG COMPRIMIDOS

CIMA_AEMPS

2024-05-27

ABILIFY MAINTENA 960 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA EN JERINGA PRECARGADA

CIMA_AEMPS

2024-05-03

ABILIFY MAINTENA 720 MG SUSPENSION INYECTABLE DE LIBERACIÓN PROLONGADA EN JERINGA PRECARGADA

CIMA_AEMPS

2024-05-03

ABILIFY MAINTENA 400 MG POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE DE LIBERACION PROLONGADA

CIMA_AEMPS

2023-11-03

INAQOVI 35 MG/100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

CIMA_AEMPS

2023-10-17

ABILIFY MAINTENA 400 MG POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE DE LIBERACION PROLONGADA

CIMA_AEMPS

2023-09-29

News

No news articles found

Back to Organizations